Translation of "response time commitment" to Danish language:
Dictionary English-Danish
Examples (External sources, not reviewed)
| Days (months) Time to response | respons CR PR (dage) a |
| We appreciate their commitment to the Community cause at a difficult time. | Fru rådsformand, jeg var meget optaget af Deres indledende personlige betragtninger. |
| Time to response CR PR (days) a | respons CR PR (dage) a |
| Time to complete response in both classifications of response ranged from 2.9 to 11.7 weeks. | Tid til komplet respons i begge responsgrupper varierede mellem 2, 9 og 11, 7 uger. |
| Additional response after this time is unlikely (see 5.1). | 5. 1). |
| 90 n ( ) Time to first response in CR PR | 90 n ( ) Tid til første respons i CR PR |
| For time to response and duration of response no difference could be recorded between the arms. | Der blev ikke registreret forskel mellem de to behandlingsarme med hensyn til tid til respons og responsvarighed. |
| COMMITMENT APPROPRIATIONS | Finansieringsform |
| Number (proportion) with 1 hour ON time response Secondary Outcome | Antallet (procentdelen) med 1 times ON tid respons Sekundært resultat Antallet (procentdelen) med |
| Overall Response Rate ( ) (95 Confidence Interval) Complete Response Partial Response Median Duration of Response (months) (95 Confidence Interval) Median time to Response (months) (95 Confidence Interval) Progression Free Survival (months) (95 Confidence Interval) Survival (months) | (måneder) (95 sikkerhedsinterval) Progressionsfri overlevelse |
| Major cytogenetic response, haematological response, molecular response (evaluation of minimal residual disease), time to accelerated phase or blast crisis and survival are main secondary endpoints. | Større cytogenetisk respons, hæmatologisk respons, molekulær respons (evaluering af minimal tilbageværende sygdom), tid til accellereret fase eller blastkrise samt overlevelse er de sekundære hovedeffektmål. |
| Major cytogenetic response, haematological response, molecular response (evaluation of minimal residual disease), time to accelerated phase or blast crisis and survival are main secondary endpoints. | Større cytogenetisk respons, hæmatologisk respons, molekylær respons (evaluering af minimal tilbageværende sygdom), tid til accellereret fase eller blastkrise samt overlevelse er de sekundære hovedeffektmål. |
| Duration of response Disease free survival (DFS) Time to new treatment | Sygdomsfri overlevelse (DFS) |
| Median time to loss of response through week 54 Week 30 | Median tid til tab af respons frem til uge 54 Uge 30 |
| Median time to loss of response through week 54 Week 54 | Median tid til tab af respons uge 54 Uge 54 |
| Commitment appropriation 1.2 | Forpligtelsesbevillinger |
| CI confidence interval, FOLFIRI irinotecan plus infusional 5 FU FA, ORR objective response rate (patients with complete response or partial response), PFS progression free survival time | CI confidence interval, konfidensinterval, FOLFIRI irinotecan plus 5 FU FA infusion, ORR objective response rate (patienter med komplet respons eller delvis respons), PFS progression free survival time |
| CI confidence interval, FOLFOX oxaliplatin plus infusional 5 FU FA, ORR objective response rate (patients with complete response or partial response), PFS progression free survival time | CI confidence interval, konfidensinterval, FOLFOX oxaliplatin plus 5 FU FA infusion, ORR objective response rate (patienter med komplet respons eller delvis respons), PFS progression free survival time |
| The start of this decisive stage in the negotiations is the response to the political commitment which was made four long years ago. | Påbegyndelsen af denne afgørende del af forhandlingen er helt i overensstemmelse med det politiske løfte, der er blevet givet for fire år siden. Fire år er en lang tid, ja, jeg vil tillade mig at sige for lang en tid. |
| (95 Confidence Interval) Complete Response Partial Response Median Duration of Response (months) (95 Confidence Interval) Median time to Response (months) (95 Confidence Interval) Progression Free Survival (months) (95 Confidence Interval) Survival (months) | (måneder) (95 sikkerhedsinterval) Progressionsfri overlevelse (måneder) (95 sikkerhedsinterval) Overlevelse (måneder) |
| The median time to response in clinical trials was 7.6 11.6 weeks. | I kliniske undersøgelser var den mediane tid indtil respons 7, 6 11, 6 uger. |
| The response to these ideologies also varies considerably with time and place. | Tilslutningen til disse ideologier varierer desuden ofte stærkt både i rum og tid. |
| The projected time for lesions that were in partial response (PR) to later attain clinical complete response (CCR) was 168 days. | Den projekterede tid for læsioner, som havde partielt respons (PR), til senere at opnå klinisk komplet respons (CCR) var 168 dage. |
| The secondary objectives included complete response (CR) and overall response (CR or partial response) rates using the 1996 NCIWG criteria, the duration of response, time to alternative treatment and safety of the two treatment arms. | De sekundære mål omfattede komplet respons (CR) og samlet respons (CR eller delvis respons), grader ved anvendelse af 1996 NCIWG kriterierne, respons varighed, tid til alternativ behandling og sikkerhed i de to behandlingsgrene. |
| The secondary objectives included complete response (CR) and overall response (CR or partial response) rates using the 1996 NCIWG criteria, the duration of response, time to alternative treatment and safety of the two treatment arms. | Lymfom lignende sygdom |
| Itemised breakdown of cost Commitment appropriations EUR million ( at current prices ) Breakdown Commitment appropriation | Omkostningernes fordeling på foranstaltningens elementer Forpligtelsesbevillinger , mio . EUR ( løbende priser ) 2002 2003 0,375 2004 0,625 2005 0,625 2006 0,25 2007 0,25 I alt 2,5 |
| Objective response rate and progression free survival time were significantly improved with cetuximab. | Den objektive responsrate og progressionsfri overlevelsestid blev signifikant forbedret med cetuximab. |
| Imputations according to the TLOVR algorithm (TLOVR Time to Loss of Virologic Response) | Imputeringer i henhold til TLOVR algoritmen (TLOVR tid til tab af virologisk respons). |
| To compare the average time to response following treatment with anagrelide or hydroxyurea. | At sammenligne den gennemsnitlige periode til respons efter behandling med anagrelid eller hydroxyurea. |
| CI confidence interval, CTX platinum based chemotherapy, ORR objective response rate, OS overall survival time, PFS progression free survival time | CI confidence interval, konfidensinterval, CTX platinbaseret kemoterapi, ORR objektiv responsrate, OS overall survival time, PFS progression free survival time |
| And the third is commitment. | Og som det tredje kommer forpligtelse. |
| The clinical response rate was 18.5 , median time to progression was 2.8 months (CI | Den kliniske responsfrekvens var 18, 5 , mediantiden for progression var 2, 8 måneder (CI |
| The MCyR rate was 27 with a median time to response of 2.0 months. | MCyR raten var 27 med en gennemsnitlig tid til respons på 2, 0 måneder. |
| Secondary efficacy endpoints included time to disease progression (TTP) and duration of response (DR). | Sekundære effektivitetsendepunker inkluderede tiden til sygdommens progression (TTP) og responsens varighed (DR duration of response). |
| The MAH reiterated their commitment to establish a test to discriminate batches of Hexavac which have elucidated a good vs. an insufficient immune response during clinical trials. | Indehaveren af markedsføringstilladelsen bekræftede sin forpligtelse til at etablere en test, som kan skelne mellem Hexavac partier, som har udvist en god immunrespons og en utilstrækkelig immunrespons under kliniske forsøg. |
Related searches: Response Time Commitment - Stimulus And Response Response - Real-time Response Time - Time Commitment - Long Time Commitment - Full Time Commitment - Working Time Commitment - Extensive Time Commitment - Commitment In Time - Commitment Of Delivery Time -
